Methods for identifying or assaying for agents that increase beta-cell proliferation, insulin secretion, insulin sensitivity, glucose tolerance and decrease fat mass
Dec 14, 2016
Columbia University has been awarded US Patent No. 9,518,976, "Methods for identifying or assaying for agents that increase beta-cell proliferation, insulin secretion, insulin sensitivity, glucose tolerance and decrease fat mass."
More Like This
Feb 22, 2017
N-of-One RapidInsights for Illumina's Trusight Tumor
N-of-One has launched the RapidInsights for Illumina TruSight Tumor 170 (TST170) panel. RapidInsights is a fully automated interpretation solution that will read bioinformatics output of the genomic variants from the TST170 panel in minutes. Results from the panel are based on the medical literature, guidelines, and clinical trials to determine the best therapies and/or trials for the patient. The solution will be available through the Philips' Intellispace Genomics solution, the company said.
This webinar will walk through key considerations and helpful guidelines to accelerate next-generation sequencing (NGS)-based clinical genomics assay validation for less money and greater confidence in results.
In this webinar, Jill Viles, an Iowa mother with no clinical training, shares her story of how she self-diagnosed her rare condition, a muscle-wasting disease caused by a mutation in the LMNA gene. She will also discuss how she discovered that a mutation in the same gene is the underlying cause for the excess muscle phenotype exhibited by Canadian Olympic hurdler Priscilla Lopes-Schliep.